Association between Expression of ERCC1, XPA and 8092C>A of ERCC1, 5'UTR of XPA Polymorphisms and Clinical Response to Cisplatin-Based Chemotherapy and Survival in Patients with Non-Seminomatous Testicular Germ Cell Tumors.

被引:0
|
作者
Mendoza, J. [1 ]
Hernandez, C. [1 ]
Martinez, J. [1 ]
Perez-Montiel, D. [1 ]
Castro, C. [1 ]
Fabian-Morales, E. [1 ]
Santibanez, M. [1 ]
Gonzalez-Barrios, R. [1 ]
Soto-Reyes, E. [1 ]
Diaz-Chavez, J. [1 ]
Onate, L. [1 ]
Jimenez, M. [1 ]
Nunez, M. [2 ]
Dyer, R. [2 ]
Herrera, L. A. [1 ]
机构
[1] Natl Canc Inst, Mexico City, DF, Mexico
[2] Inst Nacl Enfermedades Neoplas, Lima, Peru
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
1632
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Expression of ERCC1, Bcl-2, MT and their Clinical Significance in Advanced Non-small-cell Lung Cancer Treated With Cisplatin-based Chemotherapy
    Ma, Haiqing
    Sun, Huanhuan
    Huang, Fuxi
    Li, Jing
    Cao, Xiaolong
    Jiang, Wenqi
    LATIN AMERICAN JOURNAL OF PHARMACY, 2009, 28 (06): : 827 - 834
  • [22] ERCC1 MRNA EXPRESSION AND RESPONSE TO CISPLATIN-DOCETAXEL NEOADJUVANT CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER PATIENTS
    Consito, L.
    Buffoni, L.
    Grillo, R.
    Paze, E.
    Barone, C.
    Dongiovanni, D.
    Cristiano, C.
    Birocco, N.
    Ciuffreda, L.
    Schena, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [23] Expression of MRP1, BCRP, LRP and ERCC1 as prognostic factors in non-small cell lung cancer patients receiving postoperative cisplatin-based chemotherapy
    Li, Xiao-Qin
    Li, Jian
    Shi, Shun-Bing
    Chen, Ping
    Yu, Li-Chao
    Bao, Qian-Lei
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2009, 24 (04): : 230 - 237
  • [24] Response to cytotoxic chemotherapy and overall survival in non-small cell lung cancer patients with positive or negative ERCC1 expression
    Honma, Helen Naemi
    Perroud, Mauricio Wesley, Jr.
    Morcillo, Andre Moreno
    Vassallo, Jose
    Zambon, Lair
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2018, 44 (03) : 245 - 246
  • [25] Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin -: Treated advanced non-small cell lung cancer patients
    Tibaldi, Carmelo
    Giovannetti, Elisa
    Vasile, Enrico
    Mey, Valentina
    Laan, Adrie C.
    Nannizzi, Sara
    Di Marsico, Roberta
    Antonuzzo, Andrea
    Orlandini, Cinzia
    Ricciardi, Simona
    Del Tacca, Mario
    Peters, Godefridus J.
    Falcone, Alfredo
    Danesi, Romano
    CLINICAL CANCER RESEARCH, 2008, 14 (06) : 1797 - 1803
  • [26] ERCC1 immunohistochemical expression and cancer-specific survival in patients with locally advanced squamous-cell carcinoma of the head and neck treated by cisplatin-based induction chemotherapy
    Mountzios, G.
    Handra-Luca, A.
    Hernandez, J.
    Taranchon, E.
    Guily, J. Lacau-St
    Soria, J.
    Fouret, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] A prospective study of ERCC1 protein expression and gene polymorphisms in locally advanced cervical squamous cell carcinoma patients treated with cisplatin-based concurrent chemoradiotherapy
    Alvarez, A.
    Zwenger, A.
    Marechal, G.
    Acevedo, S.
    Audero, S.
    Krause, N.
    Cuevas, A.
    Yanzi, A.
    Garcia, X.
    Pallotta, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S741 - S741
  • [29] High expression of ERCC1 is a poor prognostic factor in Chinese patients with non-small cell lung cancer receiving cisplatin-based therapy
    Guo, Qing-zhi
    Wang, Jie
    Bai, Hua
    An, Tong-tong
    Wu, Meina
    Zhao, Jun
    Yang, Lu
    Duan, Jian-chun
    Wang, Yu-yan
    Wang, Zhi-jie
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (04) : 296 - 302
  • [30] Relationship between ERCC1 (C8092A) single nucleotide polymorphism and efficacy/toxicity of platinum based chemotherapy in advanced non-small cell lung cancer patients
    韦克
    周彩存
    ChinaMedicalAbstracts(Surgery), 2011, 20 (01) : 64 - 68